AZN’s Stock Market Expedition: Traversing Gains and Losses in 2025

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -6.00% this year. Over the last six months, there has been a weaker performance of 5.12%. The price of AZN fallen by 5.30% during the last 30 days period. For the last 5-days stocks have improved 2.02%.

The present stock price for Astrazeneca plc ADR (AZN) is $74.57. In the last trading session, the stock made a considerable jump, reaching $99.0 after an opening price of $74.57. The stock briefly fell to $67.0 before ending the session at $73.6.

Astrazeneca plc ADR ‘s stock market performance has been somewhat predictable.

52-week price history of AZN Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Astrazeneca plc ADR’s current trading price is -14.95% away from its 52-week high, while its distance from the 52-week low is 21.77%. The stock’s price range during this period has varied between$61.24 and $87.68. The Astrazeneca plc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 3.43 million for the day, a figure considerably lower than their average daily volume of 4.75 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Astrazeneca plc ADR (AZN) has experienced a quarterly rise of 6.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 231.20B and boasts a workforce of 94300 employees.

Astrazeneca plc ADR: Analysts’ Ratings Unveiled

As of right now, 7 analysts are rating Astrazeneca plc ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 71.08, with a change in price of -3.03. Similarly, Astrazeneca plc ADR recorded 5,175,126 in trading volume during the last 100 days, posting a change of -3.90%.

AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.58.

AZN Stock Stochastic Average

As of today, Astrazeneca plc ADR’s raw stochastic average for the last 50 days stands at 73.38%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 73.38%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 69.03% and 69.56%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.